!

URGENT: SB 432, which will enable Big Pharma to raise drug costs even higher, just moved one step closer to passing. 

New anti-inflammation drug may lower heart disease and cancer risks

August 28, 2017

A drug that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.

heartmonitoring.jpg

Image courtesy of the New York Times.

Researchers outside the study say the findings represent a major milestone — proof of a biologic concept that opens the door to new ways of treating and preventing cardiovascular disease in people who are still at risk despite standard therapies.

But experts also cautioned that potentially fatal side effects of the drug, as well as its high cost, mean it is unlikely to be widely used. Cardiovascular disease is the leading cause of death worldwide and in the United States, where it killed nearly 634,000 people in 2015. Globally, it killed 15 million."


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Lawmakers Reject Amendment to Require Drug Pricing in TV Ads
Are Rebates the New Villain of High Drug Prices?
New Bill Will Propose Mandating Price Transparency in Healthcare

Featured Articles

Tell your representative to say "no" to higher drug costs
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
AARP: Specialty Drug Costs Greatly Exceeding Median U.S. Household Income
Pharma Company Increases Drug Price by 909% as Wholesale Rates Soar
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC